NSG530: Advanced Pathophysiology Exam 1 Actual Exam 2026/2027 – Complete
Exam-Style Questions with Detailed Rationales | 100% Verified | Pass Guaranteed
– A+ Graded
SECTION 1: Cellular & Molecular Pathophysiology (Q1-Q15)
Q1: A 70-year-old male with prolonged immobilization after hip fracture demonstrates
30% reduction in quadriceps cross-sectional area on MRI. Muscle biopsy reveals
decreased myofiber size with preserved cell number. Which cellular adaptation and
underlying molecular mechanism are responsible?
A. Hypertrophy from increased protein synthesis via mTOR pathway activation
B. Atrophy from increased protein degradation via ubiquitin-proteasome and
autophagy-lysosome pathways
C. Hyperplasia from satellite cell proliferation and myonuclear accretion
D. Apoptosis from programmed cell death with DNA fragmentation
B. Atrophy from increased protein degradation via ubiquitin-proteasome and
autophagy-lysosome pathways [CORRECT]
Correct Answer: B
Rationale: Atrophy is a decrease in cell size resulting from reduced protein synthesis
and increased protein degradation. In disuse atrophy, decreased mechanical loading
,and IGF-1 signaling activate the ubiquitin-proteasome system (UPP) via
atrogin-1/MAFbx and MuRF1 E3 ubiquitin ligases, tagging contractile proteins for
proteasomal degradation. Concurrently, autophagy-lysosome pathways clear damaged
organelles and proteins. Options A and C describe growth responses, not size reduction.
Option D (apoptosis) involves programmed cell death, not reversible cell size reduction.
[100% VERIFIED – Wilkes NSG530]
Q2: A competitive weightlifter demonstrates increased skeletal muscle mass with
individual myofibers containing increased myofibrillar volume and myonuclear domain
expansion. Which molecular signaling pathway is primarily responsible for this adaptive
response?
A. AMPK activation promoting catabolic metabolism and mitochondrial biogenesis
B. IGF-1/PI3K/Akt/mTOR pathway activation stimulating protein synthesis and inhibiting
FoxO transcription factors
C. Myostatin/SMAD2/3 signaling inhibiting satellite cell activation and muscle growth
D. NF-κB pathway activation promoting inflammatory cytokine production and
proteolysis
B. IGF-1/PI3K/Akt/mTOR pathway activation stimulating protein synthesis and inhibiting
FoxO transcription factors [CORRECT]
Correct Answer: B
Rationale: Physiologic hypertrophy is driven by mechanotransduction activating the
IGF-1 receptor, which signals through PI3K to activate Akt. Akt phosphorylates and
,activates mTORC1, stimulating protein synthesis via p70S6 kinase and 4E-BP1.
Simultaneously, Akt phosphorylates FoxO transcription factors, excluding them from the
nucleus and preventing transcription of atrogin-1 and MuRF1 (E3 ligases). This dual
anabolic/anti-catabolic mechanism drives myofiber growth. Option A (AMPK) is
activated by energy stress and inhibits mTOR. Option C (myostatin) inhibits muscle
growth. Option D (NF-κB) promotes atrophy and inflammation. [100% VERIFIED – Wilkes
NSG530]
Q3: A patient with chronic gastroesophageal reflux undergoes endoscopy showing
columnar epithelium with goblet cells replacing normal squamous epithelium in the
distal esophagus. Which cellular adaptation, molecular trigger, and malignant risk are
present?
A. Dysplasia with p53 mutations and immediate invasive carcinoma
B. Metaplasia with chronic NF-κB activation from acid/bile injury and increased
adenocarcinoma risk through the dysplasia-carcinoma sequence
C. Hyperplasia with EGFR overexpression and benign proliferation
D. Hypertrophy with mTOR activation and enlarged squamous cells
B. Metaplasia with chronic NF-κB activation from acid/bile injury and increased
adenocarcinoma risk through the dysplasia-carcinoma sequence [CORRECT]
Correct Answer: B
Rationale: Metaplasia is the reversible replacement of one differentiated cell type with
another. In Barrett's esophagus, chronic acid and bile reflux activate NF-κB and
, IL-6/STAT3 signaling in esophageal stem/progenitor cells, driving transdifferentiation
from squamous to intestinal-type columnar epithelium. This metaplastic tissue is a
precursor lesion that can progress through low-grade dysplasia → high-grade dysplasia
→ invasive adenocarcinoma via accumulated genetic mutations (TP53, CDKN2A,
SMAD4). Option A incorrectly states immediate carcinoma. Options C and D describe
incorrect cellular processes. [100% VERIFIED – Wilkes NSG530]
Q4: A 45-year-old smoker has cervical cytology showing full-thickness epithelial
dysplasia with nuclear hyperchromasia, loss of polarity, and increased mitotic figures.
HPV-16 DNA is detected. Which molecular mechanisms drive this pre-malignant
transformation?
A. HPV E6/E7 oncoproteins degrading p53 and Rb tumor suppressors, promoting cell
cycle progression and genomic instability
B. HPV L1/L2 capsid proteins directly inhibiting DNA repair mechanisms
C. HPV E1/E2 replication proteins activating telomerase and preventing senescence
D. HPV-induced chronic inflammation via IL-10 secretion suppressing immune
surveillance
A. HPV E6/E7 oncoproteins degrading p53 and Rb tumor suppressors, promoting cell
cycle progression and genomic instability [CORRECT]
Correct Answer: A
Rationale: High-risk HPV types (16, 18) encode E6 and E7 oncoproteins that are
necessary and sufficient for malignant transformation. E6 binds and targets p53 for
Exam-Style Questions with Detailed Rationales | 100% Verified | Pass Guaranteed
– A+ Graded
SECTION 1: Cellular & Molecular Pathophysiology (Q1-Q15)
Q1: A 70-year-old male with prolonged immobilization after hip fracture demonstrates
30% reduction in quadriceps cross-sectional area on MRI. Muscle biopsy reveals
decreased myofiber size with preserved cell number. Which cellular adaptation and
underlying molecular mechanism are responsible?
A. Hypertrophy from increased protein synthesis via mTOR pathway activation
B. Atrophy from increased protein degradation via ubiquitin-proteasome and
autophagy-lysosome pathways
C. Hyperplasia from satellite cell proliferation and myonuclear accretion
D. Apoptosis from programmed cell death with DNA fragmentation
B. Atrophy from increased protein degradation via ubiquitin-proteasome and
autophagy-lysosome pathways [CORRECT]
Correct Answer: B
Rationale: Atrophy is a decrease in cell size resulting from reduced protein synthesis
and increased protein degradation. In disuse atrophy, decreased mechanical loading
,and IGF-1 signaling activate the ubiquitin-proteasome system (UPP) via
atrogin-1/MAFbx and MuRF1 E3 ubiquitin ligases, tagging contractile proteins for
proteasomal degradation. Concurrently, autophagy-lysosome pathways clear damaged
organelles and proteins. Options A and C describe growth responses, not size reduction.
Option D (apoptosis) involves programmed cell death, not reversible cell size reduction.
[100% VERIFIED – Wilkes NSG530]
Q2: A competitive weightlifter demonstrates increased skeletal muscle mass with
individual myofibers containing increased myofibrillar volume and myonuclear domain
expansion. Which molecular signaling pathway is primarily responsible for this adaptive
response?
A. AMPK activation promoting catabolic metabolism and mitochondrial biogenesis
B. IGF-1/PI3K/Akt/mTOR pathway activation stimulating protein synthesis and inhibiting
FoxO transcription factors
C. Myostatin/SMAD2/3 signaling inhibiting satellite cell activation and muscle growth
D. NF-κB pathway activation promoting inflammatory cytokine production and
proteolysis
B. IGF-1/PI3K/Akt/mTOR pathway activation stimulating protein synthesis and inhibiting
FoxO transcription factors [CORRECT]
Correct Answer: B
Rationale: Physiologic hypertrophy is driven by mechanotransduction activating the
IGF-1 receptor, which signals through PI3K to activate Akt. Akt phosphorylates and
,activates mTORC1, stimulating protein synthesis via p70S6 kinase and 4E-BP1.
Simultaneously, Akt phosphorylates FoxO transcription factors, excluding them from the
nucleus and preventing transcription of atrogin-1 and MuRF1 (E3 ligases). This dual
anabolic/anti-catabolic mechanism drives myofiber growth. Option A (AMPK) is
activated by energy stress and inhibits mTOR. Option C (myostatin) inhibits muscle
growth. Option D (NF-κB) promotes atrophy and inflammation. [100% VERIFIED – Wilkes
NSG530]
Q3: A patient with chronic gastroesophageal reflux undergoes endoscopy showing
columnar epithelium with goblet cells replacing normal squamous epithelium in the
distal esophagus. Which cellular adaptation, molecular trigger, and malignant risk are
present?
A. Dysplasia with p53 mutations and immediate invasive carcinoma
B. Metaplasia with chronic NF-κB activation from acid/bile injury and increased
adenocarcinoma risk through the dysplasia-carcinoma sequence
C. Hyperplasia with EGFR overexpression and benign proliferation
D. Hypertrophy with mTOR activation and enlarged squamous cells
B. Metaplasia with chronic NF-κB activation from acid/bile injury and increased
adenocarcinoma risk through the dysplasia-carcinoma sequence [CORRECT]
Correct Answer: B
Rationale: Metaplasia is the reversible replacement of one differentiated cell type with
another. In Barrett's esophagus, chronic acid and bile reflux activate NF-κB and
, IL-6/STAT3 signaling in esophageal stem/progenitor cells, driving transdifferentiation
from squamous to intestinal-type columnar epithelium. This metaplastic tissue is a
precursor lesion that can progress through low-grade dysplasia → high-grade dysplasia
→ invasive adenocarcinoma via accumulated genetic mutations (TP53, CDKN2A,
SMAD4). Option A incorrectly states immediate carcinoma. Options C and D describe
incorrect cellular processes. [100% VERIFIED – Wilkes NSG530]
Q4: A 45-year-old smoker has cervical cytology showing full-thickness epithelial
dysplasia with nuclear hyperchromasia, loss of polarity, and increased mitotic figures.
HPV-16 DNA is detected. Which molecular mechanisms drive this pre-malignant
transformation?
A. HPV E6/E7 oncoproteins degrading p53 and Rb tumor suppressors, promoting cell
cycle progression and genomic instability
B. HPV L1/L2 capsid proteins directly inhibiting DNA repair mechanisms
C. HPV E1/E2 replication proteins activating telomerase and preventing senescence
D. HPV-induced chronic inflammation via IL-10 secretion suppressing immune
surveillance
A. HPV E6/E7 oncoproteins degrading p53 and Rb tumor suppressors, promoting cell
cycle progression and genomic instability [CORRECT]
Correct Answer: A
Rationale: High-risk HPV types (16, 18) encode E6 and E7 oncoproteins that are
necessary and sufficient for malignant transformation. E6 binds and targets p53 for
